MHR对IgAN肾小球硬化严重程度的预测价值

来源期刊：广州医药 | 1482-1489 发布时间：2025-01-08 收稿时间：2025/11/13 18:42:31 阅读量：37

作者：: 陈仁芬,

陈龙庚,

郭耿耿,

陈晴,

谢祖刚,

关键词：: 单核细胞/高密度脂蛋白胆固醇比值免疫球蛋白A肾病肾小球硬化预测价值; monocyte / high-density lipoprotein cholesterol ratio immunoglobulin A nephropathy glomerulosclerosis predictive value

DOI：: 10.20223/j.cnki.1000-8535.2024.12.015

收稿时间：: 2024-04-15
修订日期：
接收日期：
引用总数：: 1

目的研究单核细胞/高密度脂蛋白比值（MHR）对免疫球蛋白A肾病（IgAN）患者肾小球硬化严重程度的预测价值。方法回顾性分析2016年1月—2022年6月龙岩人民医院收治的296例IgAN患者的临床和肾脏病理资料,参照牛津分型将患者分为无肾小球节段性硬化组（S0组）、有肾小球节段性硬化组（S1组）及球性硬化组;根据Katafuchi肾小球积分将患者分为低三分位组、中三分位组及高三分位组。比较不同肾小球硬化程度和不同Katafuchi肾小球积分患者的MHR水平,对MHR与Katafuchi肾小球积分的关系进行相关性分析,绘制受试者操作特征（ROC）曲线分析MHR对肾小球硬化程度的预测效能。结果 S1组和球性硬化组的单核细胞计数分别为（0.41±0.11）×10⁹ /L、（0.45±0.10）×10⁹ /L,均高于S0组的（0.30±0.06）×10⁹/L,对比差异有统计学意义（t₁=10.381,P₁<0.001;t₂=12.169,P₂<0.001）,球性硬化组的HDL水平为（1.14±0.16）mmoL/L,低于S0组（1.26±0.24）mmoL/L（t₂=2.992,P₂=0.003）。S1组和球性硬化组的MHR为（0.36±0.04）、（0.44±0.05）,大于S0组的（0.24±0.02）,对比差异有统计学意义（t₁=37.852,P₁<0.001;t₂=42.037,P₂<0.001）,球性硬化组的MHR大于S1组（t₃=9.673,P₃<0.001）。中三分位组和高三分位组的单核细胞计数为（0.34±0.06）×10⁹ /L、（0.48±0.10）×10⁹ /L,高于低三分位组的（0.27±0.05）×10⁹ /L,对比差异有统计学意义（t₁=9.017,P₁<0.001;t₂=20.080,P₂<0.001）,高三分位组的单核细胞计数高于中三分位组（t₃=8.855,P₃<0.001）。高三分位组的HDL水平为（0.96±0.12）mmoL/L,低于低三分位组的（1.23±0.21）mmoL/L和中三分位组的（1.19±0.16）mmoL/L,对比差异有统计学意义（t₂=8.132,P₂<0.001;t₃=7.954,P₃<0.001）。高三分位组的MHR为（0.49±0.07）,大于低三分位组的（0.25±0.03）和中三分位组（0.26±0.08）,对比差异有统计学意义（t₂=35.382,P₂<0.001;t₃=15.146,P₃<0.001）。相关性分析显示,单核细胞与Katafuchi肾小球积分呈正相关（r=0.58,P<0.05）,HDL与Katafuchi肾小球积分呈负相关（r=-0.52,P<0.05）,MHR与Katafuchi肾小球积分呈正相关（r=0.66,P<0.05）。MHR预测肾小球节段性硬化的曲线下面积（AUC）为0.609（95%CI：0.325~0.917）,此时截断值为0.29,灵敏度为68.42%,特异度为65.45%。MHR预测球性硬化的AUC为0.735（95%CI：0.527~1.001）,此时截断值为0.40,灵敏度为73.08%,特异度为66.14%。结论 MHR在预测IgAN患者肾小球硬化程度方面具有潜能。

Objective To explore predictive value of the monocyte / high-density lipoprotein ratio（MHR）on the severity of glomerulosclerosis in patients with immunoglobulin A nephropathy（IgAN）．Methods The clinical and renal pathological data of 296 IgAN patients admitted to Longyan People's Hospital from January 2016 to June 2022 were analyzed retrospectively,and the patients were divided into no segmental sclerosis group（S0）,segment sclerosis group（S1）and glomerular sclerosis group according to Oxford classification;the patients were divided into low group,middle group and high group according to Katafuchi score．MHR levels in patients with different degrees of glomerular sclerosis and different Katafuchi score were compared,the relationship between MHR and Katafuchi glomerular integration was analyzed,and ROC curves were drawn to analyze the predictive efficacy of MHR on the degree of glomerular sclerosis．Results Monocyte counts in the S1 and glomerular sclerosis groups [（0.41±0.11）10⁹ /L,（0.45±0.10）10⁹ /L] were all significantly higher than the S0 group（0.30±0.06）10⁹ /L,with statistically significant difference（t₁=10.381,P₁<0.001,t₂=12.169,P₂<0.001）．The HDL level（1.14±0.16）mmoL / L was significantly lower than that in the S0 group（1.26±0.24）mmoL / L（t₂=2.992,P₂=0.003）．The MHR in S1 and glomerular sclerosis group[（0.36±0.04）,（0.44±0.05）] were significantly greater than S0（0.24±0.02）（t₁=37.852,P₁<0.001,t₂=42.037,P₂<0.001）,and the MHR in glomerular sclerosis group was significantly greater than that of S1（t₃=9.673,P₃<0.001）．The monocyte counts of middle and high group[（0.34±0.06）10⁹/L,（0.48±0.10）10⁹/L] were significantly higher than the low group（0.27±0.05）10⁹/L（t₁=9.017,P₁<0.001;t₂=20.080,P₂<0.001）and high group was significantly higher than middle group（t₃=8.855,P₃<0.001）．The HDL level of high group（0.96±0.12）mmoL/L was significantly lower than the low group（1.23±0.21）mmoL/L and middle group（1.19±0.16）mmoL/L,with statistically significance（t₂=8.132,P₂<0.001,t₃=7.954,P₃<0.001）．The MHR（0.49±0.07）in the high group was significantly greater than the low group（0.25±0.03）and middle group（0.26±0.08）,with statistically significance（t₂=35.382,P₂<0.001,t₃=15.146,P₃<0.001）．Correlation analysis showed that monocytes were positively correlated with Katafuchi score（r=0.58,P<0.05）,HDL negatively with Katafuchi score（r=-0.52,P<0.05）,and MHR positively with Katafuchi score（r=0.66,P<0.05）．The AUC of MHR predicting segmental sclerosis was 0.609（95%CI：0.325~0.917）,when the cut-off was 0.29,sensitivity was 68.42% and specificity of 65.45%．The AUC of MHR predicting glomerulosclerosis was 0.735（95%CI：0.527~1.001）,when the cut-off was 0.40,sensitivity was 73.08% and specificity was 66.14%．Conclusions MHR has the potential in predicting the degree of glomerulosclerosis in IgAN patients．

1、梁晓玲,张春山,江琛.单核细胞与高密度脂蛋白胆固醇比值是慢性肾衰竭血液透析患者2年内死亡的独立影响因素[J].内科急危重症杂志,2023,29(2):141-145.

2、吴美豪,曹慧霞,王丽姣,等.单核细胞/高密度脂蛋白比值与慢性肾脏病疾病严重程度及预后的关系[J].中华肾脏病杂志,2021,37(7):567-575.

3、马妍,谢红浪.载脂蛋白E相关肾小球疾病的诊治进展[J].肾脏病与透析肾移植杂志,2021,30(5):470-475.

4、 KIM H J,MORADI H,YUAN J,et al.Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney[J].Am J Physiol Renal Physiol,2009,296(6):F1297-F1306.

5、王冲,王贵松,李月红.异常高密度脂蛋白在慢性肾脏病中的研究进展[J].中华肾脏病杂志,2019,35(4):316-320.

6、王娇,汪丽珍,王昱,等.基于无创指标的IgA肾病诊断预测模型的建立与验证[J].中国临床医学,2022,29(4):603-609.

7、 KORAISHY F M,BOWE B,XIE Y,et al.Monocyte count modifies the association between chronic kidney disease and risk of death[J].Clin Nephrol,2018,90(3):194-208.

8、 FONSECA F,BALLERINI A P,IZAR M C,et al.Advanced chronic kidney disease is associated with higher serum concentration of monocyte microparticles[J].Life Sci,2020(260):118295.

9、 GANJALI S,GOTTO AM,RUSCICA M,et al.Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases[J].J Cell Physiol,2018,233(12):9237-9246.

10、 KIKUCHI K,SAIGUSA D,KANEMITSU Y,et al.Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease[J].Nat Commun ,2019,10(1):1835.

11、 COOK H T.Focal segmental glomerulosclerosis in IgA nephropathy:A result of primary podocyte injury?[J].Kidney Int,2011,79(6):581-583.

12、许日聪,曹陶,徐艺,等.IgA肾病肾小球节段性硬化或粘连和肾功能下降的相关性分析[J].中华肾脏病杂志,2020,36(11):851-857.

13、 FLOEGE J,MOURA IC,DAHA MR.New insights into the pathogenesis of IgA nephropathy[J].Semin Immunopathol,2014,36(4):431-442.

14、田秀娟,黄晨.IgA肾病免疫炎症发病机制研究进展[J].中华肾脏病杂志,2020,36(5):400-405.

15、 MOROOKA M,KAWAGUCHI T,MIURA A,et al.P0370 relationship between attenuation of C3 glomerular deposition and clinical prognosis in IgA nephropathy:Repeat-biopsy based observation[J].Nephrol Dial Transplant,2020,35(Supplement_3):675.

16、陈梅,廖蕴华.原发性IgA肾病流行病学进展[J].医学研究杂志,2007,36(11):24-26.

17、 KATAFUCHI R,KIYOSHI Y,OH Y,et al.Glomerular score as a prognosticator in IgA nephropathy:Its usefulness and limitation[J].Clin Nephrol,1998,49(1):1-8.

18、 MARKOWITZ G.Glomerular disease:Updated Oxford classification of IgA nephropathy:a new MEST-C score[J].Nat Rev Nephrol,2017,13(7):385-386.

19、王永超,刘新宇.单核细胞/高密度脂蛋白胆固醇比值与2型糖尿病肾脏疾病的相关性分析[J].中国现代医学杂志,2020,30(23):77-83.

20、 TAYLOR S,WHITFIELD M,BARRATT J,et al.The metalloproteinase ADAMTS5 is expressed by interstitial inflammatory cells in IgA nephropathy and is proteolytically active on the kidney matrix[J].J Immunol,2020,205(8):2243-2254.

21、郑法雷. 肾脏病临床与进展[M].北京:人民军医出版社,2005.

22、 PENG W,TANG Y,TAN L,et al.Crescents and global glomerulosclerosis in Chinese IgA nephropathy patients:A five-year follow-up[J].Kidney Blood Press Res,2019,44(1):103-112.

23、彭思琪,卢文,江肖,等.742例原发性IgA肾病患者的临床病理特征及其预后分析[J].中华肾脏病杂志,2021,37(2):87-94.

24、弓思文. 局灶节段性肾小球硬化在IgA肾病中的发展机制[J].临床与病理杂志,2019,39(2):419-423.

25、 NAKA S,WATO K,MISAKI T,et al.Streptococcus mutans induces IgA nephropathy-like glomerulonephritis in rats with severe dental caries[J].Sci Rep,2021,11(1):5784.

26、刘泽洲,苏可,杨定平,等.IgA肾病伴高血压患者临床病理改变特征及预后分析[J].中华肾脏病杂志,2019,35(9):648-654.

1、郑颖欣,胡瑞洁.单核细胞和高密度脂蛋白胆固醇比值与视黄醇结合蛋白对肾脏病变诊断价值的研究进展[J].江西医药,2025,60(07):683-686.